Elevance Health shares are trading higher after Truist Securities maintained a Buy rating on the stock and raised its price target from $600 to $620.
Portfolio Pulse from Benzinga Newsdesk
Elevance Health shares are trading higher after Truist Securities maintained a Buy rating on the stock and raised its price target from $600 to $620.
July 16, 2024 | 2:12 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
Elevance Health shares are trading higher after Truist Securities maintained a Buy rating on the stock and raised its price target from $600 to $620.
The positive analyst rating and increased price target from a reputable firm like Truist Securities are likely to boost investor confidence and drive the stock price higher in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100